N
21.60
0.08 (0.37%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Nuvectis Pharma, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
1.3
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.33 |
|
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 46.91% |
| 机构持股比例 | 9.93% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Iridian Asset Management Llc/Ct | 30 Jun 2026 | 777,078 |
| Occam Crest Management Lp | 31 Mar 2026 | 407,147 |
| Baldwin Wealth Partners Llc/Ma | 30 Jun 2026 | 382,015 |
| Forbes J M & Co Llp | 30 Jun 2026 | 59,000 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合